Merz Pharma announces new investment in Cytrellis Biosystems
Frankfurt am Main, Germany and Boston, MA
Merz Pharma has made a strategic investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with aging.